Results of a phase II study examining venetoclax combined with chemoimmunotherapy for the first line treatment of DLBCL. (Abstract only)
Home / Resource Library / A phase II study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma